UBS Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121M | Buy |
2,812,499
+613,985
| +28% | +$26.5M | 0.02% | 678 |
|
|
2025
Q1 | $76M | Buy |
2,198,514
+358,659
| +19% | +$12.4M | 0.01% | 891 |
|
|
2024
Q4 | $50.5M | Buy |
1,839,855
+753,062
| +69% | +$20.7M | 0.01% | 1112 |
|
|
2024
Q3 | $27.7M | Sell |
1,086,793
-5,521
| -0.5% | -$141K | 0.01% | 1103 |
|
|
2024
Q2 | $27.7M | Sell |
1,092,314
-7,232
| -0.7% | -$183K | 0.01% | 1039 |
|
|
2024
Q1 | $34M | Buy |
1,099,546
+114,036
| +12% | +$3.53M | 0.01% | 934 |
|
|
2023
Q4 | $39.8M | Buy |
985,510
+832,940
| +546% | +$33.6M | 0.01% | 775 |
|
|
2023
Q3 | $4.02M | Sell |
152,570
-10,011
| -6% | -$264K | ﹤0.01% | 2019 |
|
|
2023
Q2 | $2.8M | Buy |
162,581
+77,843
| +92% | +$1.34M | ﹤0.01% | 2412 |
|
|
2023
Q1 | $1.4M | Sell |
84,738
-275,140
| -76% | -$4.56M | ﹤0.01% | 2903 |
|
|
2022
Q4 | $2.74M | Buy |
359,878
+351,065
| +3,983% | +$2.68M | ﹤0.01% | 2301 |
|
|
2022
Q3 | $88K | Sell |
8,813
-212,264
| -96% | -$2.12M | ﹤0.01% | 4758 |
|
|
2022
Q2 | $2.01M | Sell |
221,077
-220,963
| -50% | -$2.01M | ﹤0.01% | 2388 |
|
|
2022
Q1 | $4.49M | Buy |
442,040
+377,753
| +588% | +$3.83M | ﹤0.01% | 2009 |
|
|
2021
Q4 | $1.07M | Sell |
64,287
-48,438
| -43% | -$808K | ﹤0.01% | 3390 |
|
|
2021
Q3 | $5.28M | Buy |
112,725
+90,850
| +415% | +$4.26M | ﹤0.01% | 1953 |
|
|
2021
Q2 | $1.33M | Buy |
21,875
+8,534
| +64% | +$520K | ﹤0.01% | 3037 |
|
|
2021
Q1 | $822K | Sell |
13,341
-5,777
| -30% | -$356K | ﹤0.01% | 3535 |
|
|
2020
Q4 | $1.36M | Buy |
19,118
+823
| +4% | +$58.5K | ﹤0.01% | 2927 |
|
|
2020
Q3 | $686K | Sell |
18,295
-1,049
| -5% | -$39.3K | ﹤0.01% | 3173 |
|
|
2020
Q2 | $631K | Buy |
19,344
+3,424
| +22% | +$112K | ﹤0.01% | 3221 |
|
|
2020
Q1 | $462K | Sell |
15,920
-2,121
| -12% | -$61.6K | ﹤0.01% | 3283 |
|
|
2019
Q4 | $632K | Sell |
18,041
-15,658
| -46% | -$549K | ﹤0.01% | 3710 |
|
|
2019
Q3 | $723K | Buy |
33,699
+33,099
| +5,517% | +$710K | ﹤0.01% | 3441 |
|
|
2019
Q2 | $16K | Buy |
+600
| New | +$16K | ﹤0.01% | 5881 |
|